Journal Information
Vol. 47. Issue 5.
Pages 252-261 (January 2011)
Share
Share
Download PDF
More article options
Vol. 47. Issue 5.
Pages 252-261 (January 2011)
Review Article
Full text access
Respiratory Complications of Obesity
Complicaciones respiratorias de la obesidad
Visits
8210
Claudio Rabeca,
Corresponding author
claudio.rabec@chu-dijon.fr

Corresponding author.
, Pilar de Lucas Ramosb, Daniel Vealec,d
a Service de Pneumologie et Réanimation Respiratoire, CHU Dijon, Dijon, France
b Servicio de Neumología, Hospital General Universitario Gregorio Marañón, Madrid, Spain
c ANTADIR, Paris, France
d Centre de Réhabilitation Respiratoire Henri Bazire, St Julien de Ratz, France
This item has received
Article information
Abstract
Bibliography
Download PDF
Statistics
Abstract

Obesity, well known as a cardiovascular risk factor, can also lead to significant respiratory complications. The respiratory changes associated with obesity extend from a simple change in respiratory function, with no effect on gas exchange, to the more serious condition of hypercapnic respiratory failure, characteristic of obesity hypoventilation syndrome. More recently, it has been reported that there is an increased prevalence of asthma which is probably multifactorial in origin, but in which inflammation may play an important role. Hypoventilation in the obese subject is the result of complex interactions that involve changes in the ventilatory mechanics and anomalies in breathing control. Two other conditions (COPD and sleep apneahypopnea syndrome [SAHS], often present in obese patients, can trigger or aggravate it. The prevalence of hypoventilation in the obese is under-estimated and the diagnosis is usually established during an exacerbation, or when the patient is studied due to suspicion of SAHS. Ventilatory management of these patients, ventilatory management of these patients includes either CPAP or NIV. The choice of one or another will depend on the underlying clinical condition and whether or not there is another comorbidity. Both NIV and CPAP have demonstrated their effectiveness, not only in the control of gas exchange, but also in improving the quality of life and survival of these patients

Keywords:
Obesity
Obesity-hypoventilation syndrome
Non-invasive ventilation
Continuous positive airway pressure
Respiratory failure
Resumen

La obesidad, bien conocida como factor de riesgo cardiovascular, puede asimismo comportar una importante afectación respiratoria. Las alteraciones respiratorias relacionadas con la obesidad abarcan desde la simple alteración de la función ventilatoria, sin consecuencias sobre el intercambio gaseoso, hasta la situación más grave, la insuficiencia respiratoria hipercápnica característica del síndrome de obesidad hipoventilación. Más recientemente se ha señalado la presencia de un incremento de prevalencia de asma de probable etiología multifactorial pero en el que puede desempeñar un papel importante la inflamación. La hipoventilación en el sujeto obeso es el resultado de complejas interacciones que implican a las alteraciones de la mecánica ventilatoria y a anomalías del control ventilatorio. Otras dos entidades (enfermedad pulmonar obstructiva crónica y síndrome de apnea hipopnea del sueño [SAHS]), frecuentemente presentes en los pacientes obesos, pueden potenciarla o agravarla. La prevalencia de hipoventilación en el obeso se encuentra subestimada y es frecuente que el diagnóstico sólo se establezca con motivo de una exacerbación o cuando el paciente es estudiado por sospecha de SAHS. El manejo ventilatorio de estos pacientes, mediante CPAP o ventilación no invasiva (VNI), dependerá de la situación clínica subyacente y de la presencia o no de otra comorbilidad. Tanto la VNI como la CPAP han mostrado su eficacia no sólo en el control de las alteraciones gasométricas, sino también en la mejora de la calidad de vida y en la supervivencia de los pacientes

Palabras clave:
Obesidad
Síndrome obesidad-hipoventilación
Ventilación no invasiva
Presión positiva continua en la vía respiratoria
Insuficiencia respiratoria
Full text is only aviable in PDF
References
[1.]
M.A. Charles, E. Eschwege, A. Basdevant.
Monitoring the obesity epidemic in france: the obepi surveys 1997-2006.
Obesity (Silver Spring), 16 (2008), pp. 2182-2186
[3.]
F.J. Basterra-Gortari, M. Bes-Rastrollo, M. Segui-Gomez, L. Forga, J.A. Martinez, M.A. Martinez-Gonzalez.
Trends in obesity, diabetes mellitus, hypertension and hypercholesterolemia in Spain (1997-2003).
Med Clin (Barc), 129 (2007), pp. 405-408
[4.]
J. Fry, W. Finley.
The prevalence and costs of obesity in the EU.
Proc Nutr Soc, 64 (2005), pp. 359-362
[5.]
B. Mokhlesi, A. Tulaimat.
Recent advances in obesity hypoventilation syndrome.
Chest, 132 (2007), pp. 1322-1336
[6.]
Dickens C. The posthumous paper of the Pickwick Club. In: Chapman J, Hall A, editors. London, published in serial form, 1836-37.
[7.]
A.G. Bickelmann, C.S. Burwell, E.D. Robin, R.D. Whaley.
Extreme obesity associated with alveolar hypoventilation;a Pickwickian syndrome.
Am J Med, 21 (1956), pp. 811-818
[8.]
P. De Lucas Ramos, J.M. Rodriguez Gonzalez-Moro, Y. Rubio Socorro.
Obesity and lung function.
Arch Bronconeumol, 40 (2004), pp. 27-31
[9.]
D.F. Rochester, Y. Enson.
Current concepts in the pathogenesis of the obesityhypoventilation syndrome. Mechanical and circulatory factors.
Am J Med, 57 (1974), pp. 402-420
[10.]
S.M. Koenig.
Pulmonary complications of obesity.
Am J Med Sci, 321 (2001), pp. 249-279
[11.]
R.L. Jones, M.M. Nzekwu.
The effects of body mass index on lung volumes.
Chest, 130 (2006), pp. 827-833
[12.]
L.C. Collins, P.D. Hoberty, J.F. Walker, E.C. Fletcher, A.N. Peiris.
The effect of body fat distribution on pulmonary function tests.
Chest, 107 (1995), pp. 1298-1302
[13.]
R.W. Vaughan, R.C. Cork, D. Hollander.
The effect of massive weight loss on arterial oxygenation and pulmonary function tests.
Anesthesiology, 54 (1981), pp. 325-328
[14.]
K. Hakala, P. Mustajoki, J. Aittomaki, A.R. Sovijarvi.
Effect of weight loss and body position on pulmonary function and gas exchange abnormalities in morbid obesity.
Int J Obes Relat Metab Disord, 19 (1995), pp. 343-346
[15.]
I. Rubinstein, N. Zamel, L. DuBarry, V. Hoffstein.
Airflow limitation in morbidly obese, nonsmoking men.
Ann Intern Med, 112 (1990), pp. 828-832
[16.]
C.S. Ray, D.Y. Sue, G. Bray, J.E. Hansen, K. Wasserman.
Effects of obesity on respiratory function.
Am Rev Respir Dis, 128 (1983), pp. 501-506
[17.]
M. Hulens, G. Vansant, R. Lysens, A.L. Claessens, E. Muls.
Exercise capacity in lean versus obese women.
Scand J Med Sci Sports, 11 (2001), pp. 305-309
[18.]
L. Seres, J. Lopez-Ayerbe, R. Coll, O. Rodriguez, J.M. Manresa, J. Marrugat, et al.
Cardiopulmonary function and exercise capacity in patients with morbid obesity.
Rev Esp Cardiol, 56 (2003), pp. 594-600
[19.]
A. Salvadori, P. Fanari, M. Fontana, L. Buontempi, A. Saezza, S. Baudo, et al.
Oxygen uptake and cardiac performance in obese and normal subjects during exercise.
Respiration, 66 (1999), pp. 25-33
[20.]
M.J. Gallagher, B.A. Franklin, J.K. Ehrman, S.J. Keteyian, C.A. Brawner, A.T. de Jong, et al.
Comparative impact of morbid obesity vs heart failure on cardiorespiratory fitness.
Chest, 127 (2005), pp. 2197-2203
[21.]
J.P. Laaban, D. Cassuto, E. Orvoen-Frija, F. Lenique.
Respiratory complications of massive obesity.
Rev Prat, 42 (1992), pp. 469-476
[22.]
T. Akashiba, T. Akahoshi, S. Kawahara, A. Uematsu, K. Katsura, S. Sakurai, et al.
Clinical characteristics of obesity-hypoventilation syndrome in Japan: a multicenter study.
Intern Med, 45 (2006), pp. 1121-1125
[23.]
J.P. Laaban, E. Chailleux.
Daytime hypercapnia in adult patients with obstructive sleep apnea syndrome in France, before initiating nocturnal nasal continuous positive airway pressure therapy.
Chest, 127 (2005), pp. 710-715
[24.]
B. Mokhlesi, A. Tulaimat, I. Faibussowitsch, Y. Wang, A.T. Evans.
Obesity hypoventilation syndrome: prevalence and predictors in patients with obstructive sleep apnea.
Sleep Breath, 11 (2007), pp. 117-124
[25.]
F. Han, E. Chen, H. Wei, Q. He, D. Ding, K.P. Strohl.
Treatment effects on carbon dioxide retention in patients with obstructive sleep apnea-hypopnea syndrome.
Chest, 119 (2001), pp. 1814-1819
[26.]
M.G. Sampson, K. Grassino.
Neuromechanical properties in obese patients during carbon dioxide rebreathing.
Am J Med, 75 (1983), pp. 81-90
[27.]
M.G. Sampson, A.E. Grassino.
Load compensation in obese patients during quiet tidal breathing.
J Appl Physiol, 55 (1983), pp. 1269-1276
[28.]
N. Chouri-Pontarollo, J.C. Borel, R. Tamisier, B. Wuyam, P. Levy, J.L. Pepin.
Impaired objective daytime vigilance in obesity-hypoventilation syndrome: impact of noninvasive ventilation.
Chest.\, 131 (2007), pp. 148-155
[29.]
R. Jokic, T. Zintel, G. Sridhar, C.G. Gallagher, M.F. Fitzpatrick.
Ventilatory responses to hypercapnia and hypoxia in relatives of patients with the obesity hypoventilation syndrome.
Thorax, 55 (2000), pp. 940-945
[30.]
A.L. Olson, C. Zwillich.
The obesity hypoventilation syndrome.
Am J Med, 118 (2005), pp. 948-956
[31.]
Y. Chen, D. Rennie, Y. Cormier, J. Dosman.
Sex specificity of asthma associated with objectively measured body mass index and waist circumference: the Humboldt study.
Chest, 128 (2005), pp. 3048-3054
[32.]
W. Nystad, H.E. Meyer, P. Nafstad, A. Tverdal, A. Engeland.
Body mass index in relation to adult asthma among 135,000 Norwegian men and women.
Am J Epidemiol, 160 (2004), pp. 969-976
[33.]
S.Y. Young, J.D. Gunzenhauser, K.E. Malone, A. McTiernan.
Body mass index and asthma in the military population of the northwestern United States.
Arch Intern Med, 161 (2001), pp. 1605-1611
[34.]
F. Vazquez Nava, A.H. Saldivar Gonzalez, G. Martinez Perales, D. Lin Ochoa, M.C. Barrientos Gomez, E.M. Vazquez Rodriguez, et al.
Associations between family history of allergy, exposure to tobacco smoke, active smoking, obesity, and asthma in adolescents.
Arch Bronconeumol, 42 (2006), pp. 621-626
[35.]
W.S. Beckett, D.R. Jacobs, X. Yu, C. Iribarren, O.D. Williams.
Asthma is associated with weight gain in females but not males, independent of physical activity.
Am J Respir Crit Care Med, 164 (2001), pp. 2045-2050
[36.]
C.A. Camargo, S.T. Weiss, S. Zhang, W.C. Willett, F.E. Speizer.
Prospective study of body mass index, weight change, and risk of adult-onset asthma in women.
Arch Intern Med, 159 (1999), pp. 2582-2588
[37.]
Y. Chen, R. Dales, M. Tang, D. Krewski.
Obesity may increase the incidence of asthma in women but not in men: longitudinal observations from the Canadian National Population Health Surveys.
Am J Epidemiol, 155 (2002), pp. 191-197
[38.]
E.S. Ford, D.M. Mannino, S.C. Redd, A.H. Mokdad, J.A. Mott.
Body mass index asthma and incidence among USA adults.
Eur Respir adults J, 24 (2004), pp. 740-744
[39.]
D.A. Beuther, E.R. Sutherland.
Overweight, obesity, and incident asthma: a metaanalysis of prospective epidemiologic studies.
Am J Respir Crit Care Med, 175 (2007), pp. 661-666
[40.]
V. Flaherman, G.W. Rutherford.
A meta-analysis of the effect of high weight on asthma.
Arch Dis Child, 91 (2006), pp. 334-339
[41.]
D.D. Sin, E.R. Sutherland.
Obesity and the lung: 4. Obesity and asthma.
Thorax, 63 (2008), pp. 1018-1023
[42.]
J.A. Castro-Rodriguez.
Relationship between obesity and asthma.
Arch Bronconeumol, 43 (2007), pp. 171-175
[43.]
G. Fantuzzi, Adipose tissue.
adipokines, and inflammation [quiz 920].
J Allergy Clin Immunol, 115 (2005), pp. 911-919
[44.]
S.A. Shore.
Obesity and asthma: cause for concern.
Curr Opin Pharmacol, 6 (2006), pp. 230-236
[45.]
A. Sood.
Obesity, adipokines, and lung disease.
J Appl Physiol, 108 (2010), pp. 744-753
[46.]
S.A. Shore, I.N. Schwartzman, M.S. Mellema, L. Flynt, A. Imrich, R.A. Johnston.
Effect of leptin on allergic airway responses in mice.
J Allergy Clin Immunol, 115 (2005), pp. 103-109
[47.]
S.A. Shore, R.D. Terry, L. Flynt, A. Xu, C. Hug.
Adiponectin attenuates allergen-induced airway inflammation and hyperresponsiveness in mice.
J Allergy Clin Immunol, 118 (2006), pp. 389-395
[48.]
L.M. Schachter, C.M. Salome, J.K. Peat, A.J. Woolcock.
Obesity is a risk for asthma and wheeze but not airway hyperresponsiveness.
Thorax, 56 (2001), pp. 4-8
[49.]
S.D. Aaron, D. Fergusson, R. Dent, Y. Chen, K.L. Vandemheen, R.E. Dales.
Effect of weight reduction on respiratory function and airway reactivity in obese women.
Chest, 125 (2004), pp. 2046-2052
[50.]
C.R. McLachlan, R. Poulton, G. Car, J. Cowan, S. Filsell, J.M. Greene, et al.
Adiposity, asthma, and airway inflammation.
J Allergy Clin Immunol, 119 (2007), pp. 634-639
[51.]
Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research.
The Report of an American Academy of Sleep Medicine Task Force. Sleep., 22 (1999), pp. 667-689
[52.]
T. Young, M. Palta, J. Dempsey, J. Skatrud, S. Weber, S. Badr.
The occurrence of sleepdisordered breathing among middle-aged adults.
N Engl J Med, 328 (1993), pp. 1230-1235
[53.]
R. Carter, D.E. Watenpaugh.
Obesity and obstructive sleep apnea: Or is it OSA and obesity?.
Pathophysiology, 15 (2008), pp. 71-77
[54.]
O. Resta, M.P. Foschino-Barbaro, G. Legari, S. Talamo, P. Bonfitto, A. Palumbo, et al.
Sleep-related breathing disorders, loud snoring and excessive daytime sleepiness in obese subjects.
Int J Obes Relat Metab Disord, 25 (2001), pp. 669-675
[55.]
F. Crummy, A.J. Piper, M.T. Naughton.
Obesity and the lung: 2. Obesity and sleepdisordered breathing.
Thorax, 63 (2008), pp. 738-746
[56.]
M. Basta, H.M. Lin, S. Pejovic, A. Sarrigiannidis, E. Bixler, A.N. Vgontzas.
Lack of regular exercise, depression, and degree of apnea are predictors of excessive daytime sleepiness in patients with sleep apnea: sex differences.
J Clin Sleep Med, 4 (2008), pp. 19-25
[57.]
M. Esler, M. Rumantir, G. Wiesner, D. Kaye, J. Hastings, G. Lambert.
Sympathetic nervous system and insulin resistance: from obesity to diabetes.
Am J Hypertens, 14 (2001), pp. 304S-309S
[58.]
E. Tasali, R. Leproult, D.A. Ehrmann, E. Van Cauter.
Slow-wave sleep and the risk of type 2 diabetes in humans.
Proc Natl Acad Sci U S A, 105 (2008), pp. 1044-1049
[59.]
R. Kessler, A. Chaouat, P. Schinkewitch, M. Faller, S. Casel, J. Krieger, et al.
The obesity-hypoventilation syndrome revisited: a prospective study of 34 consecutive cases.
Chest, 120 (2001), pp. 369-376
[60.]
C.A. Rabec.
Obesity hypoventilation syndrome: what's in a name?.
Chest, 122 (2002), pp. 1498
[61.]
I. Ayappa, K.I. Berger, R.G. Norman, B.W. Oppenheimer, D.M. Rapoport, R.M. Goldring.
Hypercapnia and ventilatory periodicity in obstructive sleep apnea syndrome.
Am J Respir Crit Care Med, 166 (2002), pp. 1112-1115
[62.]
K.I. Berger, I. Ayappa, I.B. Sorkin, R.G. Norman, D.M. Rapoport, R.M. Goldring.
Postevent ventilation as a function of CO(2) load during respiratory events in obstructive sleep apnea.
J Appl Physiol, 93 (2002), pp. 917-924
[63.]
M.Y. Lee, C.C. Lin, S.Y. Shen, C.H. Chiu, S.F. Liaw.
Work of breathing in eucapnic and hypercapnic sleep apnea syndrome.
Respiration, 77 (2009), pp. 146-153
[64.]
C.C. Lin, K.M. Wu, C.S. Chou, S.F. Liaw.
Oral airway resistance during wakefulness in eucapnic and hypercapnic sleep apnea syndrome.
Respir Physiol Neurobiol, 139 (2004), pp. 215-224
[65.]
J. De Miguel Diez, P. De Lucas Ramos, J.J. Perez Parra, M.J. Buendia Garcia, J.M. Cubillo Marcos, J.M. Gonzalez-Moro.
Analysis of withdrawal from noninvasive mechanical ventilation in patients with obesity-hypoventilation syndrome Medium term results.
Arch Bronconeumol, 39 (2003), pp. 292-297
[66.]
E. Weitzenblum.
Pickwickian syndrome reconsidered. Relations between sleep apnea syndrome and obesity-hypoventilation syndrome.
Rev Prat, 42 (1992), pp. 1920-1924
[67.]
C.S. Mantzoros.
The role of leptin in human obesity and disease: a review of current evidence.
Ann Intern Med, 130 (1999), pp. 671-680
[68.]
C.P. O’Donnell, C.G. Tankersley, V.P. Polotsky, A.R. Schwartz, P.L. Smith.
Leptin, obesity, and respiratory function.
Respir Physiol, 119 (2000), pp. 163-170
[69.]
R.V. Considine, M.K. Sinha, M.L. Heiman, A. Kriauciunas, T.W. Stephens, M.R. Nyce, et al.
Serum immunoreactive-leptin concentrations in normal-weight and obese humans.
N Engl J Med, 334 (1996), pp. 292-295
[70.]
C. Tankersley, S. Kleeberger, B. Russ, A. Schwartz, P. Smith.
Modified control of breathing in genetically obese (ob/ob) mice.
J Appl Physiol, 81 (1996), pp. 716-723
[71.]
C.G. Tankersley, C. O’Donnell, M.J. Daood, J.F. Watchko, W. Mitzner, A. Schwartz, et al.
Leptin attenuates respiratory complications associated with the obese phenotype.
J Appl Physiol, 85 (1998), pp. 2261-2269
[72.]
C.W. Atwood.
Sleep-related hypoventilation: the evolving role of leptin.
Chest, 128 (2005), pp. 1079-1081
[73.]
V.Y. Polotsky, J.A. Wilson, M.C. Smaldone, A.S. Haines, P.D. Hurn, C.G. Tankersley, et al.
Female gender exacerbates respiratory depression in leptin-deficient obesity.
Am J Respir Crit Care Med, 164 (2001), pp. 1470-1475
[74.]
J.F. Caro, J.W. Kolaczynski, M.R. Nyce, J.P. Ohannesian, I. Opentanova, W.H. Goldman, et al.
Decreased cerebrospinal-fluid/serum leptin ratio in obesity: a possible mechanism for leptin resistance.
Lancet, 348 (1996), pp. 159-161
[75.]
P.R. Phipps, E. Starritt, I. Caterson, R.R. Grunstein.
Association of serum leptin with hypoventilation in human obesity.
Thorax, 57 (2002), pp. 75-76
[76.]
B.J. Yee, J. Cheung, P. Phipps, D. Banerjee, A.J. Piper, R.R. Grunstein.
Treatment of obesity hypoventilation syndrome and serum leptin.
Respiration, 73 (2006), pp. 209-212
[77.]
B.M. Sanner, P. Kollhosser, N. Buechner, W. Zidek, M. Tepel.
Influence of treatment on leptin levels in patients with obstructive sleep apnoea.
Eur Respir J, 23 (2004), pp. 601-604
[78.]
K. Tatsumi, Y. Kasahara, K. Kurosu, N. Tanabe, Y. Takiguchi, T. Kuriyama.
Sleep oxygen desaturation and circulating leptin in obstructive sleep apnea-hypopnea syndrome.
Chest, 127 (2005), pp. 716-721
[79.]
T. Ulukavak Ciftci, O. Kokturk, N. Bukan, A. Bilgihan.
Leptin and ghrelin levels in patients with obstructive sleep apnea syndrome.
Respiration, 72 (2005), pp. 395-401
[80.]
M.S. Ip, K.S. Lam, C. Ho, K.W. Tsang, W. Lam.
Serum leptin and vascular risk factors in obstructive sleep apnea.
Chest, 118 (2000), pp. 580-586
[81.]
K. Chin, K. Shimizu, T. Nakamura, N. Narai, H. Masuzaki, Y. Ogawa, et al.
Changes in intra-abdominal visceral fat and serum leptin levels in patients with obstructive sleep apnea syndrome following nasal continuous positive airway pressure therapy.
Circulation, 100 (1999), pp. 706-712
[82.]
R. Shimura, K. Tatsumi, A. Nakamura, Y. Kasahara, N. Tanabe, Y. Takiguchi, et al.
Fat accumulation, leptin, and hypercapnia in obstructive sleep apnea-hypopnea syndrome.
Chest, 127 (2005), pp. 543-549
[83.]
K.I. Berger, I. Ayappa, B. Chatr-Amontri, A. Marfatia, I.B. Sorkin, D.M. Rapoport, et al.
Obesity hypoventilation syndrome as a spectrum of respiratory disturbances during sleep.
Chest, 120 (2001), pp. 1231-1238
[84.]
S. Nowbar, K.M. Burkart, R. Gonzales, A. Fedorowicz, W.S. Gozansky, J.C. Gaudio, et al.
Obesity-associated hypoventilation in hospitalized patients: prevalence, effects, and outcome.
Am J Med, 116 (2004), pp. 1-7
[85.]
A. Kopka, E. Wallace, G. Reilly, A. Binning.
Observational study of perioperative PtcCO2 and SpO2 in non-ventilated patients receiving epidural infusion or patient-controlled analgesia using a single earlobe monitor (TOSCA).
Br J Anaesth, 99 (2007), pp. 567-571
[86.]
B. Stenius-Aarniala, T. Poussa, J. Kvarnstrom, E.L. Gronlund, M. Ylikahri, P. Mustajoki.
Immediate and long term effects of weight reduction in obese people with asthma: randomised controlled study.
BMJ, 320 (2000), pp. 827-832
[87.]
E.S. Ford.
The epidemiology of obesity and asthma [quiz 910].
J Allergy Clin Immunol, 115 (2005), pp. 897-909
[88.]
H.J. Sugerman, R.P. Fairman, R.K. Sood, K. Engle, L. Wolfe, J.M. Kellum.
Long-term effects of gastric surgery for treating respiratory insufficiency of obesity.
Am J Clin Nutr, 55 (1992), pp. 597S-601S
[89.]
M. Maniscalco, A. Zedda, S. Faraone, M.R. Cerbone, S. Cristiano, C. Giardiello, et al.
Weight loss and asthma control in severely obese asthmatic females.
Respir Med, 102 (2008), pp. 102-108
[90.]
H. Buchwald, Y. Avidor, E. Braunwald, M.D. Jensen, W. Pories, K. Fahrbach, et al.
Bariatric surgery: a systematic review and meta-analysis.
JAMA, 292 (2004), pp. 1724-1737
[91.]
F. Del Campo Matias, J. De Frutos Arribas, A. Sanchez Fernandez.
Acute respiratory failure immediately following surgery for morbid obesity.
Arch Bronconeumol, 44 (2008), pp. 449-450
[92.]
G. Pillar, R. Peled, P. Lavie.
Recurrence of sleep apnea without concomitant weight increase 7.5 years after weight reduction surgery.
Chest, 106 (1994), pp. 1702-1704
[93.]
P.K. Plant, J.L. Owen, M.W. Elliott.
Early use of non-invasive ventilation for acute exacerbations of chronic obstructive pulmonary disease on general respiratory wards: a multicentre randomised controlled trial.
Lancet, 355 (2000), pp. 1931-1935
[94.]
A. Ciledag, A. Kaya, B.B. Akdogan, P.A. Kabalak, Z.P. Onen, E. Sen, et al.
Early use of noninvasive mechanical ventilation in patients with acute hypercapnic respiratory failure in a respiratory ward: a prospective study.
Arch Bronconeumol, 46 (2010), pp. 538-542
[95.]
C. Rabec, M. Merati, N. Baudouin, P. Foucher, T. Ulukavac, O. Reybet-Degat.
Management of obesity and respiratory insufficiency. The value of dual-level pressure nasal ventilation.
Rev Mal Respir, 15 (1998), pp. 269-278
[96.]
G. Sampol, G. Rodes, J. Rios, O. Romero, P. Lloberes, F. Morell.
Acute hypercapnic respiratory failure in patients with sleep apneas.
Arch Bronconeumol, 46 (2010), pp. 466-472
[97.]
L.A. Perez de Llano, R. Golpe, M. Ortiz Piquer, A. Veres Racamonde, M. Vazquez Caruncho, O. Caballero Muinelos, et al.
Short-term and long-term effects of nasal intermittent positive pressure ventilation in patients with obesityhypoventilation syndrome.
Chest, 128 (2005), pp. 587-594
[98.]
L.A. Perez de Llano, R. Golpe, M.O. Piquer, A.V. Racamonde, M.V. Caruncho, M.J. Lopez, et al.
Clinical heterogeneity among patients with obesity hypoventilation syndrome: therapeutic implications.
Respiration, 75 (2008), pp. 34-39
[99.]
D. Banerjee, B.J. Yee, A.J. Piper, C.W. Zwillich, R.R. Grunstein.
Obesity hypoventilation syndrome: hypoxemia during continuous positive airway pressure.
Chest, 131 (2007), pp. 1678-1684
[100.]
A.J. Piper, C.E. Sullivan.
Effects of short-term NIPPV in the treatment of patients with severe obstructive sleep apnea and hypercapnia.
Chest, 105 (1994), pp. 434-440
[101.]
M. Maniscalco, A. Zedda, S. Faraone, P. Carratu, M. Sofia.
Evaluation of a transcutaneous carbon dioxide monitor in severe obesity.
Intensive Care Med, 34 (2008), pp. 1340-1344
[102.]
D. Robert, L. Argaud.
Non-invasive positive ventilation in the treatment of sleeprelated breathing disorders.
Sleep Medicine, 8 (2007), pp. 441-452
[103.]
P. De Lucas-Ramos, J. De Miguel-Diez, A. Santacruz-Siminiani, J.M. Gonzalez-Moro, M.J. Buendia-Garcia, J.L. Izquierdo-Alonso.
Benefits at 1 year of nocturnal intermittent positive pressure ventilation in patients with obesity-hypoventilation syndrome.
Respir Med, 98 (2004), pp. 961-967
[104.]
S. Redolfi, L. Corda, G. La Piana, S. Spandrio, P. Prometti, C. Tantucci.
Long-term noninvasive ventilation increases chemosensitivity and leptin in obesityhypoventilation syndrome.
Respir Med, 101 (2007), pp. 1191-1195
[105.]
F. Heinemann, S. Budweiser, J. Dobroschke, M. Pfeifer.
Non-invasive positive pressure ventilation improves lung volumes in the obesity hypoventilation syndrome.
Respir Med, 101 (2007), pp. 1229-1235
[106.]
C.M. Dolan, K.E. Fraher, E.R. Bleecker, S.L. Borish, S.B. Chipps, Hayden S.
M. L. Design and baseline characteristics of the epidemiology and natural history of asthma: Outcomes and Treatment Regimens (TENOR) study: a large cohort of patients with severe or difficult-to-treat asthma..
Ann Allergy Asthma Immunol, 92 (2004), pp. 32-39
[107.]
M. Peters-Golden, A. Swern, S.S. Bird, C.M. Hustad, E. Grant, J.M. Edelman.
Influence of body mass index on the response to asthma controller agents.
Eur Respir J, 27 (2006), pp. 495-503
[108.]
D.D. Sin, R.L. Jones, S.F. Man.
Obesity is a risk factor for dyspnea but not for airflow obstruction.
Arch Intern Med, 162 (2002), pp. 1477-1481
[109.]
P. De Lucas Ramos, J.M. Rodriguez Gonzalez-Moro, L. Paz Gonzalez, A. Santa-Cruz Siminiani, J.M. Cubillo Marcos.
Current status of home mechanical ventilation in Spain: results of a national survey.
Arch Bronconeumol, 36 (2000), pp. 545-550
[110.]
J.P. Janssens, S. Derivaz, E. Breitenstein, B. De Muralt, J.W. Fitting, J.C. Chevrolet, et al.
Changing patterns in long-term noninvasive ventilation: a 7-year prospective study in the Geneva Lake area.
Chest, 123 (2003), pp. 67-79
[111.]
E. Chiner, M. Llombart, M.A. Martinez-Garcia, E. Fernandez-Fabrellas, R. Navarro, A. Cervera.
Noninvasive mechanical ventilation in Valencia Spain: from theory to practice.
Arch Bronconeumol, 45 (2009), pp. 118-122
[112.]
A. Ortega Gonzalez, G. Peces-Barba Romero, I. Fernandez Ormaechea, R. Chumbi Flores, N. Cubero de Frutos, N. Gonzalez Mangado.
Evolution of patients with chronic obstructive pulmonary disease, obesity hypoventilation syndrome or congestive heart failure in a respiratory monitoring unit.
Arch Bronconeumol, 42 (2006), pp. 423-429
[113.]
J.F. Masa, B.R. Celli, J.A. Riesco, M. Hernandez, J. Sanchez De Cos, C. Disdier.
The obesity hypoventilation syndrome can be treated with noninvasive mechanical ventilation.
Chest, 119 (2001), pp. 1102-1107
[114.]
C. Rabec, A. Cuvelier.
The obesity-hypoventilation syndrome.
Rev Pneumol Clin, 65 (2009), pp. 225-236
Copyright © 2011. Sociedad Española de Neumología y Cirugía Torácica
Archivos de Bronconeumología
Article options
Tools

Are you a health professional able to prescribe or dispense drugs?